Atazanavir Capsules and Factor VIIa (Recombinant)
Determining the interaction of Atazanavir Capsules and Factor VIIa (Recombinant) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: atazanavir
Brand name: Reyataz
Synonyms: Atazanavir
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: Coagulation factor VIIa (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atazanavir Capsules-Factor X (Human)
- Atazanavir Capsules-Factor x human Intravenous
- Atazanavir Capsules-Factor XIII
- Atazanavir Capsules-Factor XIII (Human)
- Atazanavir Capsules-Factor XIII A-Subunit (Recombinant)
- Atazanavir Capsules-Factor XIII Concentrate (Human)
- Factor VIIa (Recombinant)-Atazanavir Powder for Oral Suspension
- Factor VIIa (Recombinant)-Atazanavir Sulfate
- Factor VIIa (Recombinant)-Atelvia
- Factor VIIa (Recombinant)-Atendia Patch
- Factor VIIa (Recombinant)-Atenolol
- Factor VIIa (Recombinant)-Atenolol and chlorthalidone